GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sugentech Inc (XKRX:253840) » Definitions » Additional Paid-In Capital

Sugentech (XKRX:253840) Additional Paid-In Capital : ₩68,627 Mil(As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sugentech Additional Paid-In Capital?


Sugentech's quarterly additional paid-in capital increased from Sep. 2023 (₩67,248 Mil) to Dec. 2023 (₩68,377 Mil) and increased from Dec. 2023 (₩68,377 Mil) to Mar. 2024 (₩68,627 Mil).

Sugentech's annual additional paid-in capital declined from Dec. 2021 (₩98,560 Mil) to Dec. 2022 (₩64,894 Mil) but then increased from Dec. 2022 (₩64,894 Mil) to Dec. 2023 (₩68,377 Mil).


Sugentech Additional Paid-In Capital Historical Data

The historical data trend for Sugentech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sugentech Additional Paid-In Capital Chart

Sugentech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 106,361.72 97,150.36 98,560.02 64,893.62 68,376.58

Sugentech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65,316.43 64,234.48 67,248.31 68,376.58 68,626.72

Sugentech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sugentech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sugentech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sugentech (XKRX:253840) Business Description

Traded in Other Exchanges
N/A
Address
87, Techno 2-ro, Yuseong-gu, Daejeon, KOR
Sugentech Inc is an in-vitro diagnostic company. It is developing and selling products that can diagnose many types of diseases based on various platforms such as self-diagnostics home testing products (Self-testing) and Point-of-care testing(POCT) products.

Sugentech (XKRX:253840) Headlines

No Headlines